Aziyo Biologics Inc.

7.23+0.5200+7.75%Vol 31.88K1Y Perf -34.09%
Jun 24th, 2022 16:00 DELAYED
BID2.78 ASK10.83
Open7.00 Previous Close6.71
Pre-Market- After-Market7.08
 - -  -0.15 -2.07%
Target Price
10.50 
Analyst Rating
Strong Buy 1.00
Potential %
45.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     32.80
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     26.59
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
44.71 
Earnings Rating
Market Cap98.47M 
Earnings Date
8th Aug 2022
Alpha-0.01 Standard Deviation0.19
Beta-0.49 

Today's Price Range

6.757.23

52W Range

4.1011.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
14.58%
1 Month
19.31%
3 Months
33.15%
6 Months
8.40%
1 Year
-34.09%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AZYO7.230.52007.75
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.62-0.603.23
Q04 2021-0.64-0.82-28.12
Q03 2021-0.61-0.81-32.79
Q02 2021-0.55-0.2358.18
Q01 2021-0.57-0.5012.28
Q04 2020-0.51-0.57-11.76
Q03 2020-2.37-15.79-566.24
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date8th Aug 2022
Estimated EPS Next Report-0.55
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume31.88K
Shares Outstanding13.62K
Shares Float1.77M
Trades Count451
Dollar Volume223.68K
Avg. Volume8.80K
Avg. Weekly Volume8.48K
Avg. Monthly Volume7.17K
Avg. Quarterly Volume10.77K

Aziyo Biologics Inc. (NASDAQ: AZYO) stock closed at 7.23 per share at the end of the most recent trading day (a 7.75% change compared to the prior day closing price) with a volume of 31.88K shares and market capitalization of 98.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 163 people. Aziyo Biologics Inc. CEO is Ronald K. Lloyd.

The one-year performance of Aziyo Biologics Inc. stock is -34.09%, while year-to-date (YTD) performance is 14.76%. AZYO stock has a five-year performance of %. Its 52-week range is between 4.1 and 11.1, which gives AZYO stock a 52-week price range ratio of 44.71%

Aziyo Biologics Inc. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 13.10, a price-to-sale (PS) ratio of 1.28, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -41.62%, a ROC of -67.42% and a ROE of -242.70%. The company’s profit margin is -60.68%, its EBITDA margin is -41.20%, and its revenue ttm is $46.00 Million , which makes it $4.94 revenue per share.

Of the last four earnings reports from Aziyo Biologics Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.55 for the next earnings report. Aziyo Biologics Inc.’s next earnings report date is 08th Aug 2022.

The consensus rating of Wall Street analysts for Aziyo Biologics Inc. is Strong Buy (1), with a target price of $10.5, which is +45.23% compared to the current price. The earnings rating for Aziyo Biologics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aziyo Biologics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aziyo Biologics Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 27.31, ATR14 : 0.53, CCI20 : 237.27, Chaikin Money Flow : 0.11, MACD : 0.13, Money Flow Index : 60.79, ROC : 15.13, RSI : 63.89, STOCH (14,3) : 100.00, STOCH RSI : 1.00, UO : 55.51, Williams %R : 0.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aziyo Biologics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aziyo Biologics Inc.

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

CEO: Ronald K. Lloyd

Telephone: +1 240 247-1170

Address: 12510 Prosperity Drive, Silver Spring 20904, MD, US

Number of employees: 163

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

46%54%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

News

Stocktwits